Tuesday, October 26, 2021: 5:00 PM-7:00 PM
Exhibit Hall (Rosen Shingle Creek)
The Effect of Evobrutinib, a Bruton’s Tyrosine Kinase Inhibitor, on Blood Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis
Jens Kuhle, MD, PhD, University Hospital Basel, and University of Basel;
Ludwig Kappos, MD, University Hospital Basel, and University of Basel;
Xavier Montalban, MD, PhD, Hospital Universitario Vall d'Hebron;
Ying Li, MS, Global Clinical Development Center;
Karthinathan Thangavelu, PhD, Global Clinical Development Center;
Yann Hyvert, PhD, Merck KGaA;
Davorka Tomic, PhD, Merck KGaA
Concentration of Evobrutinib, a Bruton’s Tyrosine Kinase Inhibitor, in Cerebrospinal Fluid during Treatment of Patients with Relapsing Multiple Sclerosis in a Phase 2 Study
Karolina Piasecka-Stryczynska, PhD, Poznan University of Medical Sciences;
Konrad Rejdak, MD, PhD, Medical University of Lublin;
Martin Dyroff, PhD, EMD Serono Research & Development Institute, Inc (an affiliate of Merck KGaA, Darmstadt, Germany);
Yann Hyvert, PhD, Merck KGaA;
Kristina Holmberg, PhD, EMD Serono Research & Development Institute, Inc (an affiliate of Merck KGaA, Darmstadt, Germany);
Matthew Mandel, MD, EMD Serono Research & Development Institute, Inc (an affiliate of Merck KGaA, Darmstadt, Germany);
Carolina Cunha, PhD, PharmD, EMD Serono Research & Development Institute, Inc (an affiliate of Merck KGaA, Darmstadt, Germany);
David Mitchell, PhD, Nuventra Inc.;
Emily C. Martin, PhD, EMD Serono Research & Development Institute, Inc (an affiliate of Merck KGaA, Darmstadt, Germany);
Xavier Montalban, MD, PhD, Hospital Universitari Vall d’Hebron
Combinatorial Analysis of Plasma and DNA Methylation Biomarkers in African American Patients with Multiple Sclerosis
Lindsay Clark, PhD, University of Illinois;
Mark Band, PhD, University of Illinois;
Jason P. Mendoza, PhD, Biogen;
Linda Piccinini, PhD, Biogen;
Michael D Carrithers, MD, PhD, University of Illinois College of Medicine, Jesse Brown Veterans Hospital
Predicting Stress Levels and Response to a Self-Management Program Using Participant Demographic, Clinical, and Biomarker Data: A Secondary Analysis
Nico Osier, PhD, RN, The University of Texas at Austin, Dell Medical School;
Alexa Stuifbergen, PhD, RN, FAAN, The University of Texas at Austin;
Sawyer Stubbs, BS, University of Texas at Austin;
Tapasvini Paralkar, BS, University of Texas at Austin
